cycloheximide has been researched along with abt-199 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aryal, N; Boiko, S; Cidado, J; Drew, L; Fawell, SE; Gregory, GP; Hattersley, M; Johnstone, RW; Proia, T; Saeh, JC; San Martin, M; Shao, W; Wu, MM | 1 |
1 other study(ies) available for cycloheximide and abt-199
| Article | Year |
|---|---|
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas.
Topics: Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cyclin-Dependent Kinase 9; Cycloheximide; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Leupeptins; Lymphoma, Large B-Cell, Diffuse; Macrocyclic Compounds; Mice; Mice, Inbred NOD; Mice, SCID; Minor Histocompatibility Antigens; Molecular Targeted Therapy; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Peptide Fragments; Piperazines; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyridines; Sulfonamides; Xenograft Model Antitumor Assays | 2021 |